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Hydrogen peroxideHaematopoietic stem and progenitor cell (HSC) therapy may be promising for the treatment of inﬂammatory
bowel disorders (IBDs). However, clinical success remains poor, partly explained by limited HSC recruitment
following systemic delivery. The mechanisms governing HSC adhesion within inﬂamed colon, and whether
this event can be enhanced, are not known. An immortalised HSC-like line (HPC7) was pre-treated with hydro-
gen peroxide (H2O2), activated platelet releasate enriched supernatant (PES) or platelet microparticles (PMPs).
Subsequent adhesion was monitored using adhesion assays or in vivo ischaemia–reperfusion (IR) and colitis
injured mouse colon intravitally. Integrin clustering was determined confocally and cell morphology using
scanning electron microscopy. Both injuries resulted in increased HPC7 adhesion within colonic mucosal
microcirculation. H2O2 and PES signiﬁcantly enhanced adhesion in vitro and in the colitis, but not IR injured,
colon. PMPs had no effect on adhesion. PES and PMPs induced clustering of integrins on the HPC7 surface, but
did not alter their expression. Adhesion to the colon is modulated by injury but only in colitis injury can this
recruitment be enhanced. The enhanced adhesion induced by PES is likely through integrin distribution changes
on the HPC7 surface. Improving local HSC presence in injured colon may result in better therapeutic efﬁcacy for
treatment of IBD.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inﬂammatory and ischaemic bowel injuries such as Crohn's and
colitis are difﬁcult to treat, with current treatments rapidly losing
effectiveness. Hence there is a pressing need for new, effective options
to be identiﬁed. Evidence suggests that haematopoietic stem cell
(HSC) therapy may be an effective treatment option for inﬂammatory
gastrointestinal disorders (Singh et al., 2010; Lanzoni et al., 2008;
Garcia-Bosch et al., 2010). HSCs confer beneﬁt in experimental models
of colitis and in Crohn's disease patients. This was originally thought
to be due to direct repair of tissue by HSCs transdifferentiating into
non-haematologic cells of the gut, but is now considered to be primarily
due to combatting the excessive immune responses triggered by
these inﬂammatory injuries through paracrine immunomodulatory
mechanisms (Oyama et al., 2005; Wei et al., 2009). Administration of
adult CD34+ stemcells (SCs) improves clinical scores and signiﬁcantly re-
ducesmortality in dextran sodium sulphate (DSS)-inducedmurine colitis. This is an open access article under(Khalil et al., 2007). Furthermore, coeliac patients have increased circulat-
ing CD34+ cells when compared with healthy controls (Mastrandrea
et al., 2008). There have also been several promising trials utilising HSCs
as a therapy for Crohn's disease, with initial reports suggesting some
improvement although recurrence rates remained high (Burt et al.,
2010; Hawkey 2012).
Despite ongoing trials, it is clear that clinical efﬁcacy of cellular
therapies is either minor or transitory. Poor success has been partially
explained by a limited number of systemically transplanted SCs
interacting with local microvessels (Karp and Teo, 2009; Kavanagh
and Kalia, 2011). Considering the extension of the inﬂamed intestine,
systemic infusion of cellular therapy offers a less invasive mode of
delivery than multiple localised injections directly into the bowel
and thus requires less HSCs (Karp and Teo, 2009). Furthermore, this
preferred route of SC administration most closely mimics how endog-
enous bone marrow-derived HSCs may participate physiologically in
tissue regeneration. Capture of exogenously administered circulating
HSCs by injured tissue microvasculature is therefore a prerequisite
event for successful therapy, regardless of the subsequent mecha-
nisms underlying HSC-mediated repair. However, systemic injection
is associated with low levels of SC retention in injured tissues. Indeed,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with most cells not demonstrating sustained engraftment (Aicher
et al., 2003). Furthermore, difﬁculties remain in obtaining sufﬁciently
large quantities of high purity HSCs using existing culture conditions.
Therefore, identiﬁcation of methodologies that improve or enhance
SC recruitment to injured tissue microcirculation is a current high
priority for cellular therapies (Karp and Teo, 2009; Kavanagh and
Kalia, 2011). Although attempts have been made to enhance stem/
progenitor cell recruitment using genetically modiﬁed cells or by
increasing the local concentration of potent SC chemoattractants
within injured tissue, non-invasive techniques, not requiring genetic
manipulation, is more appealing.
It is well established that a host of factors within the injured
microenvironment are capable of activating circulating leukocytes and
platelets and thus permitting their endothelial adhesion during inﬂam-
matory processes (Mori et al., 2005a; Vowinkel et al., 2007; Sprague and
Khalil, 2009; Santen et al., 2010). A potent leukocyte pro-adhesive
modulator foundwithinmany inﬂammatory environments, particularly
the ischaemic and colitis gut, is the free radical hydrogen peroxide
(H2O2), generated locally by endothelium and inﬁltrating neutrophils
(Fraticelli et al., 1996; Damiani et al., 2007). Similar factors most likely
activate trafﬁcking SCs as they circulate through damaged tissue. We
hypothesised that pre-treatment of HSCs with such factors would
increase the likelihood of their adhesion. Indeed, we have previously
demonstrated that H2O2 pre-treatment enhances adhesion of an
immortalised HSC-like line (HPC7) within the ischaemia-reperfusion
(IR) injured small intestine (SI) in vivo (Kavanagh et al., 2013a). This
increase was mediated by clustering α4 and β2 integrins on the HPC7
surface, increasing their afﬁnity for endothelial counterligands such as
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion
molecule-1 (VCAM-1), and inducing HPC7 pro-migratory ﬁlopodia for-
mation. Whether H2O2 pre-treated HSCs can adhere within the injured
colon more efﬁciently than naïve HSCs is not known. An alternative
strategy could involve HSC pre-treatment with the use of biological
factors such as platelet derived microparticles (PMPs). On activation,
platelets release these small (b1 μm)membranous vesicles that express
many of the surface receptors found on platelets (Burnouf et al., 2014).
PMPs are the biggest source of microparticles within humans and are
known to be increased in various pathologies, including Crohn's disease
(Chamouard et al., 2005). Initially, it was thought that PMPs were
cellular debris without any distinct physiological or pathological
function. However, it is increasingly evident that PMPs have many
roles, including an ability to increase neutrophil adhesion by transfer
of adhesion molecules to their surface (Jy et al., 1995). The use of
PMPs as a pre-treatment option for HSCs is attractive as they have
not only been shown to enhance HSC recruitment to bone marrow
(Janowska-Wieczorek et al., 2001), but also increase cellular repair
efﬁciency independently of affects on adhesion (Burnouf et al., 2014;
Mause et al., 2010).
Determining whether systemic administration of transplanted
HSCs can efﬁciently deliver cells to intestinal tissues, and whether
this phenomenon can be enhanced, has received little attention, with
no studies conducted in the injured colon in vivo. Therefore in this
study, we used intravital microscopy, a methodology with single-cell
sensitivity, to ﬁrstly detail the homing kinetics of an immortalised
HSC-like line (HPC7) to the murine colon following two distinctly
different injuries, namely an acute IR injury and a more chronic colitis
injury. We further elucidated the molecular adhesive mechanisms
governing HSC homing to injured colonic microvessels. Having already
demonstrated an ability for H2O2 to improve HPC7 retention within IR
injured SI, we tested this pre-treatment strategy within the two colon
injury models. The efﬁcacy of this chemical strategy was also
compared with HPC7s pre-coated with PMPs. This is the ﬁrst study
to have tested HSC homing to two models of colonic injury and also
utilised two distinctly different pre-treatment strategies in an attempt
to enhance their local presence.2. Materials and methods
2.1. Animals
Male C57Bl/6 mice (Harlan, UK) were used for procedures in
accordance with the Animals (Scientiﬁc Procedures) Act of 1986
(Project Licence: 40/3336, 40/3226 or 30/2721). Anaesthetized animals
(ketamine/xylazine administered intraperitoneally) underwent carotid
artery cannulation to facilitate infusion of ﬂuorescently labelled HPC7s
and maintenance anaesthesia. The colon was exteriorised by gently
moving the caecum out of the abdominal cavity and held in place with
atraumatic hooks. A longitudinal cautery incision, made in the ascend-
ing colon along the anti-mesenteric border, was held open using
atraumatic hooks. The exposed mucosa was cleaned gently with saline
and a coverslip placed on it to improve image clarity when imagingmi-
croscopically. The mucosa was visualised using an upright ﬂuorescent
intravital microscope (×10 objective; BX61WI, Olympus). Images
were captured and analysed using Slidebook V.5 (Intelligent Imaging
Innovations, USA). Colonic blood ﬂow was quantitated using the same
preparation and monitored using a Moor FPLI laser speckle imager
(Moor Instruments, UK).
2.2. Colon injury models and intravital microscopy
Intestinal IR injury was induced by occlusion of the superior mesen-
teric artery (SMA) with a non-traumatic clamp for 45 min and subse-
quent removal to initiate reperfusion. Control animals underwent
sham surgery in which the SMAwas isolated but not clamped. A single
bolus dose of 2 × 106 CFSE labelled HPC7s was injected via the carotid
artery cannula at 1 h reperfusion. Colitis injurywas induced by allowing
ad libitum access to 3% dextran sodium sulphate (DSS, MW36-50 kDa;
MP Biomedicals, UK) in drinking water for 5 days. All colitis mice met
a threshold injury score to ensure injury status as previously described
(Cooper et al., 1993). For trackingHPC7s in the colitis colon,ﬂuorescent-
ly labelled cells were infused via the carotid artery once the surgical
preparation for intravital imaging was completed and the colon had
been allowed to stabilise for 30 min. In both IR and colitis mice, a single
pre-selected ﬁeld of view was imaged intravitally every 5 min for 1 h.
Adherent HPC7s were deﬁned as those that remained stationary for
N30 s. Free ﬂowing HPC7s were deﬁned as those that passed through
the ﬁeld of view without slowing or becoming stationary. At no point
were HPC7s seen to be rolling in the colonic microvasculature. For all
experiments, the colon was excised at the end of intravital imaging
and 5 additional ﬁelds of viewwere monitored ex vivo. This was to en-
sure the adhesive events in the pre-selected area for IR and colitis mice
were representative of events taking place in thewhole colon. The lungs
were also analysed ex vivo to quantitate HPC7 presence in at least 5
random ﬁelds of view.
2.3. Platelet microparticle generation
Platelets were isolated from the descending aorta of donor C57BL/6
mice following CO2 narcosis, into 100 μl acid citrate dextrose (120 mM
sodium citrate, 110 mM glucose, 80 mM citric acid). Blood was diluted
in Tyrode's-HEPES buffer (134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM
KCl, 12 mM NaHCO3, 20 mM HEPES, 5 mM glucose, 1 mM MgCl2,
pH 7.3) and centrifuged (200 ×g, 5 min) to obtain a platelet rich plasma
(PRP). The PRP was spiked with 10 μg/ml of prostacyclin and centri-
fuged at 1000 ×g for 6 min, the platelet pellet washed and counted
and ﬁnally resuspended in Stem Pro SFM 34 (Invitrogen, UK) at
3× 107/ml. Plateletswere subsequently activatedwith 2U/ml of throm-
bin for 30min and then centrifuged at 1000 ×g for 6min. The pellet was
discarded and the supernatant kept and classed as a platelet microparti-
cle enriched supernatant (PES). This contained not only the platelet mi-
croparticles but also the soluble factors released by platelets following
their activation. To generate puriﬁed platelet microparticles (PMP), the
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tantwas then removed and the pellet resuspended in an equal volume of
StemPro SFM34. This PMP contained only themicroparticles andnot the
releasate from the activated platelets. PES and PMP suspensions were
used within 30 min of being generated.
2.4. Haematopoietic stem cells and pre-treatment protocols
Investigating the homing of individual HSCs at a cellular level
using intravital microscopy has been hampered by the limited num-
ber of primary HSCs obtainable from individual mice (Kavanagh and
Kalia, 2011). Therefore, an immortalised HSC line, HPC7, generated
by transfecting embryonic SCs with the murine LIM-homeobox
gene LH2 was used. HPC7s display many characteristics of primary
HSCs including surface expression of common murine HSC markers
(c-kit+, CD34−, Lin−) (Pinto do et al., 1998) and similar behaviour
at a molecular level (Pinto do et al., 2002). Importantly, these cells
also reconstitute haematopoiesis when injected into lethally irradiat-
ed hosts (Pinto do et al., 2002). HPC7 cells also express adhesion
molecules present on primary HSCs such as CD18 and CD49d, and
we have used them extensively to model HSC recruitment to murine
organs other than the gut, including the liver and kidney (Kavanagh
et al., 2013a; White et al., 2013; Kavanagh et al., 2013b; Kavanagh
et al., 2010). Cells were maintained at a density of 1 × 106 cells/ml
in supplemented Stem Pro 34 serum free media (Life Technologies,
UK), 100 ng/ml rmSCF (Life Technologies, UK), L-glutamine, penicillin
and streptomycin.
We have previously demonstrated that pre-treatment of HPC7swith
100 μMH2O2 enhanced their adhesion to endothelial cells in vitro and IR
injured SI in vivo (Kavanagh et al., 2013a). Therefore, the same concen-
tration was utilised for the current experiments in the colon. HPC7s
were incubated at 37 °C with 100 μM H2O2 for 1 h at a density of
2 × 106 cells/ml. Some cells were incubated at 37 °C with either PES,
PMP or thrombin for 1 h at a density of 4 × 106 cells/ml. HPC7s were
then washed by centrifugation and resuspended in un-supplemented
Stem Pro at the required density immediately prior to use. To visualise
HPC7s, they were ﬂuorescently labelled with 5 μM (5/6)-carboxyﬂuo-
rescein diacetate succinimidyl ester (CFDA-SE; Life Technologies, UK)
prior to in vitro and in vivo imaging. For intravital studies, 2 × 106
CFSE labelled cells were injected as a bolus dose via the carotid artery.
To determine whether HPC7 surface integrin subunits CD18 (β2) and
CD49d (α4) mediated their recruitment in vivo, function blocking anti-
bodies to these intrgrins were used. 2 × 106 HPC7s were incubated in
80 μg/ml of either LEAF™ (low endotoxin, azide free) rat anti-mouse
CD18 (Game 46; BD Pharmingen, UK), rat anti-mouse CD49d (R1-2;
Cambridge Bioscience, UK) or rat IgG (RTK2758; Cambridge Bioscience,
UK) for 15min,washed by centrifugation and used immediately follow-
ing wash.
2.5. Flow cytometry
Wehave previously documented the effects of H2O2 onHPC7 surface
integrin expression (Kavanagh et al., 2013a). In the current study, ﬂow
cytometry was also used to determine changes in integrin expression
following PES and PMP incubation. HPC7s were resuspended in PBS
containing 5% FBS and were then incubated with a primary ﬂuorescent
antibody at a concentration of 1:250 for 15 min. Antibodies used were
ﬂuorescein isothiocyanate (FITC) conjugated rat anti-mouse CD49d
(R1-2, Cambridge Bioscience, UK), FITC rat anti-mouse CD18 (Game-
46; Santa Cruz Biotechnology, USA) or FITC rat anti-mouse IgG
(poly4060; Biolegend, UK). Cells were then washed in cold PBS and ex-
pression analysed using a BD FACSCalibur (Beckton Dickinson, USA)
ﬂow cytometer and analysed using Summit v.4.3 (Dako Cytomation).
Flow cytometry was also used to determine whether PMPs coated the
surface of HPC7s following incubation by measuring increases in the
expression of platelet surface markers, namely GPIIb/CD41 (GPIIbcomponent of GPIIbIIIa integrin) and GPIbα/CD42 (GPIbα component
of GPIb–V–IX complex) on the HPC7 surface. This was assessed using
FITC conjugated rat anti-mouse GPIIb (MWReg30; BD Biosciences,
UK), FITC conjugated rat anti-mouse GPIb (Clone: Xia.B2, Emfret,
Germany) or FITC rat anti-mouse IgG (poly4060; Biolegend, UK).
2.6. Confocal and electron microscopy
The physical interaction of PMPs with HPC7s was also further
conﬁrmed confocally in two different ways. Firstly, in order to visualise
PMPs, a platelet rich plasmawas incubatedwith DiOC6 at a ﬁnal concen-
tration of 4 μg/ml and mixed gently in the dark for 30 min. DiOC6 (3,3′-
dihexyloxacarbocyanine iodide) is a cell permeant, green ﬂuorescent
dye used for staining the membrane of vesicles. Platelets were washed
as described above and were then activated with thrombin and stained
microparticles were isolated. Attachment of DiOC6 labelled PMPs to
HPC7s was visualised confocally. Interactions were also visualised con-
focally by labelling HPC7s with CellTracker Orange (CTO; Invitrogen,
UK; red) and incubating with platelet microparticles labelled with an
anti-GPIb monoclonal antibody, counterstained with Alexa Fluor-488
antibody (green).
We have previously determined the effects of H2O2 on HPC7 surface
integrin clustering (Kavanagh et al., 2013a). In the current study, confo-
cal microscopy was also used to monitor integrin clustering following
PES and PMP pre-treatment. CTO labelled HPC7s were incubated with
PES, PMP or thrombin, formalin ﬁxed and then incubated with either
LEAF rat anti-mouse CD18 or LEAF rat anti-mouse CD49d for 60 min
on ice. Cells were washed and incubated with Alexa488 goat anti-rat
IgG (Invitrogen, UK) for 30 min on ice. Cells were washed thoroughly
and allowed to settle onto poly-L-lysine coated coverslips overnight
and then mounted using Hydromount (Fisher Scientiﬁc, UK) ready for
confocal imaging (Leica TCS-SP2; ×63 oil immersion lens). Off-line
image analysis of clustering was conducted using ImageJ software
(NIH, US).
Scanning electron microscopy (SEM) was utilised to assess pheno-
typic changes in HPC7s following PES/PMP pre-treatment and was
performed on 2% glutaraldehyde ﬁxed coated HPC7s. Brieﬂy, samples
were settled onto poly-L-Lysine coverslips overnight, dehydrated
through a graded ethanol series and critical point dried and mounted
onto SEM stubs. Samples were coated with evaporated carbon and
examined using a Jeol 7000F SEM.
2.7. Static adhesion assays
Adhesion of HPC7s to endothelium, immobilised endothelial
counterligands and frozen colon tissue sections were also assessed
in vitro. Immortalised colon endothelial cells (CECs) were a kind gift
from Prof. Steven Alexander (Louisiana State University, USA). CECs
were maintained in culture on gelatin coated ﬂasks in D-Valine
Minimum Essential Media (Promocell, UK), 10% foetal bovine serum
(FBS, Invitrogen, UK), 50 μg/ml streptomycin, 50 U/ml penicillin,
2 mM L-glutamine, 1/100 non-essential amino acids (Sigma, UK),
1/100 vitamin mix (Gibco, UK) and 10 U/ml mIFNγ (Peprotech, UK)
at 33 °C, 5% CO2. For experiments, CECs were cultured on the base
of 24 well tissue culture dishes at 37 °C, 5% CO2 in Dulbecco's
Modiﬁed Eagles Medium (4.5 g/l glucose; Invitrogen, UK), 10% FBS,
50 U/ml penicillin, 50 μg/ml streptomycin until conﬂuency. 4 h
prior to experiment wells were stimulated with 100 U/ml TNFα
(Peprotech, UK), then washed thoroughly prior to addition of
HPC7s. CECs were grown to conﬂuency and HPC7s were added for
20 min at 37 °C, washed with PBS and then ﬁxed with 2% glutaralde-
hyde (Sigma, UK) before imaging. We have previously compared the
adhesion of HPC7s and primary lineage negative (Lin−) cells to
endothelium with and without an array of different pre-treatment
strategies (White et al., 2013). This particular subset of cells was se-
lected as it provides a sufﬁcient number of cells from three donor
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obtained showed that the HPC7 line responded to all the tested
pre-treatment strategies in a similar way to primary cells.To determine adhesion to immobilised counterligands, ﬂat bot-
tomed 96-well plates were coated with 500 ng of murine VCAM-1,
ICAM-1 (R&D Systems, UK) or 1% bovine serum albumin in phosphate
573A. Yemm et al. / Stem Cell Research 15 (2015) 569–580buffered saline (PBSA) for 60 min at room temperature. Wells were
washed twice and subsequently blocked with 1% PBSA for 60 min at
room temperature. 105 treated HPCs in 50 μl were incubated on the
well surface for 20 min at 37 °C. Wells were washed twice and ﬁxed
in 2% glutaraldehyde for 15 min at 37 °C. Wells were then washed
twice and 100 μl PBS added prior to imaging using an inverted micro-
scope (Olympus IX81). Frozen colon tissue sections were prepared by
taking 20 mm lengths of excised ascending colon, opened to expose
the mucosa and snap frozen in liquid nitrogen. Tissue sections were
then cryostat sectioned to remove 20 μm from the mucosal surface in
order to expose the mucosal vasculature. Tissues were subsequently
stored at−80 °C until ready for use.
2.8. Hydrogen peroxide in tissue
H2O2 content in colon tissues was assessed as previously described
(Kavanagh et al., 2013a) using PeroXOquant Quantitative Peroxide
Assay Kit (Thermo Scientiﬁc, UK) as permanufacturer's instructions. Sim-
ilarly, 8-oxo-2′-deoxyguanosine staining was performed as previously
described (Kavanagh et al., 2013a) on 10 μm transverse cryosectioned
colon tissue.
3. Statistics
All statistical analyses and graph plotting were performed using
Prism GraphPad v4 (GraphPad Software Inc., USA). The area under the
curve (AUC) values were calculated using the same software for each
intravital and laser speckle experiment from the serial data plots and
presented alongside the serial plots as bar charts. This is themost appro-
priate way of statistically interpreting serial measurements such as
these. The AUC mean + SEM values were calculated and ANOVA with
Dunnett's post-test used to test for signiﬁcant differences. Some exper-
iments were analysed using Student's t-test as appropriate. Details of
statistical tests are contained within ﬁgure legends. Data is presented
as mean + standard error or mean (SEM) in all cases.
4. Results
4.1. HPC7 adhesion to IR and colitis injured colon is increased despite poor
blood ﬂow
HPC7 adhesion to frozen sections of IR and colitis colon was signiﬁ-
cantly (p b 0.01) increased in vitro by ~2 fold when compared with
healthy sham control tissue (Fig. 1A). Similar increases in adhesion
were also observed in vivo in IR and colitis injured colonic mucosa
when assessed intravitally (Fig. 1B–C). Indeed, AUC analysis demon-
strated signiﬁcant increases in HPC7 adhesion in IR (p b 0.01) and colitis
mice (p b 0.05) (Fig. 1B: right side). Therewas no difference in the num-
ber of free ﬂowing cells observed trafﬁcking through the colitis colon
microcirculation and, after ﬁrst pass, HPC7 were generally not observed
again. However, there was a small but signiﬁcant (p b 0.05) increase in
free ﬂowing cells within IR injured colon immediately after their
injection as determined when analysing AUC data for free ﬂowing
cells (Fig. 1B). Since intravital microscopy determined adhesion within
a single, randomly pre-selected region of the colonic mucosa, ex vivo
analysis of multiple sites in excised tissues, removed at the end of
in vivo imaging, was used to conﬁrm the intravital data. Again, HPC7
adhesion was increased in IR and colitis colon (Fig. 1D). A very highFig. 1. Inﬂammatory injury to the colon results in increased recruitment of HSCs. (A) HSC adhes
shams. (B) Intravital microscopy also demonstrated increasedHSC adhesionwithin both IR and
(lower left). The right panels display the area under the curve (AUC) data for these intravital gr
injured colons. (D) Ex vivo analysis of excised tissues conﬁrmed increases in HSC adhesion to I
(E) IR and colitis injury resulted in reduced blood ﬂow (measured asmean ﬂux) to colonmucos
for region delineated by black line. (F) Images from in vivo laser speckle microscopy are show
presented as mean ± SEM. Statistical analysis performed with (A) 2 way ANOVA and (B–D
*p b 0.05, **p b 0.01; ***p b 0.001.number of HPC7s were present within the lungs of all mice with no dif-
ferences between groups (Fig. 1D). It was possible that the increased
HPC7 adhesion observed in vivo occurred as a result of greater blood
perfusion (hyperemic response to injury), leading to a greater delivery
of cells to the injured colon. However, laser specklemicroscopy demon-
strated that in both IR and colitis injury, the mucosa had signiﬁcantly
lower blood ﬂow compared with the sham tissue (Figs. 1E–F). Indeed,
AUC analysis demonstrated a signiﬁcantly lower blood ﬂow in both IR
(p b 0.01) and colitis (p b 0.01) injured colons (Fig. 1E: right side).
4.2. HPC7 integrins govern adhesion within injured colon but in an injury
speciﬁc manner
Functionally blocking CD18 on HPC7s resulted in a signiﬁcant (p b
0.001) reduction in their adhesion to IR injured colon (Fig. 2A), but
was not observed when CD49d was blocked. There was no effect ob-
served on the number of free ﬂowing cells trafﬁcking through the
colon (data not presented). Ex vivo analysis of multiple additional
sites in the colon conﬁrmed these results but it also demonstrated that
pulmonary retention was not integrin dependent (Fig. 2B: right side).
Blocking either CD18 or CD49d signiﬁcantly (p b 0.05) reduced HPC7
recruitment within colitis injured colon (Fig. 2C). Again, there was no
effect on thenumber of freeﬂowing cells observed (data not presented).
It is noteworthy that when CD18 was blocked on HPC7s infused into IR
injuredmice, HPC7 adhesion was reduced to the baseline values seen in
sham colons. However, blocking either HPC7 CD18 or CD49d did not
lower adhesion to baseline values in the colitis colon, suggesting a
possible redundancy in the adhesion molecules used in this injury.
Again ex vivo analysis of tissues reﬂected what was observed in vivo
and pulmonary recruitmentwas again not affected (Figs. 2D: right side).
4.3. Pre-treating HPC7s with H2O2 enhances adhesion but only in the colitis
colon in vivo
H2O2 was signiﬁcantly (p b 0.05) increased within homogenised IR
injured colonic tissue. Although raised in the colitis colon, it did not
attain statistical signiﬁcance (Fig. 3A). Similarly, 8-oxo-dG labelling in
colon tissue sections revealed that both IR and colitis injury resulted in
greater amounts of oxidative damage within the colon when compared
with sham tissue (Fig. 3B). As shown earlier in Fig. 1A, HPC7 adhesion to
frozen sections of IR and colitis colon was signiﬁcantly (p b 0.01) in-
creased in vitro (Fig. 1A). However, this adhesion was enhanced on all
colon tissue sectionswhenHPC7swere pre-treatedwithH2O2 including
sham (p b 0.001), IR (p b 0.01) and colitis tissue sections (p b 0.05)
(Fig. 3C). Interestingly, H2O2 pre-treatment did not increase adhesion
to the IR injured colon when imaging intravitally in vivo (Fig. 3D). Ex
vivo analysis supported these intravital observations but it also demon-
strated that the number of HPC7s within the lungs was not altered
either (Fig. 3E: right side). However, pre-treatment did signiﬁcantly
(p b 0.05) increase adhesion within the colitis colon in vivo (Fig. 3F),
which was conﬁrmed by AUC analysis of the date (Fig. 3F: right side).
Again, ex vivo analysis supported these observations and showed no
changes in pulmonary recruitment (Fig. 3G: right side). H2O2 pre-
treatment did not affect the number of free ﬂowing cells in either IR
or colitis colon (data not presented). The inability of H2O2 to enhance
HPC7 adhesion to IR injured colon was speculated to be due to the
systemically delivered cells becoming recruited to the simultaneously
injured small intestine, thus limiting the pool of circulating HPC7sion is increased on IR and colitis injured frozen colon tissue comparedwith vehicle treated
colitis injured colons (upper left) but nomajor changes in the number of free ﬂowing HSCs
aphs. (C) Representative intravital images of the mucosa from sham, IR injured and colitis
R and colitis injured colon and also demonstrated high numbers of HSCs within the lungs.
a. Black line represents data used for statistical comparison. Right panel displays AUC data
n in which red indicates areas of high blood ﬂow and blue, areas of least blood ﬂow. Data
) 1 way ANOVA with Bonferroni post-test comparisons. N ≥ 5–6 mice for each group;
Fig. 2. HSC adhesion within injured colon is integrin mediated, but differs depending on injury. (A) Blocking HSC surface CD18, but not CD49d, reduced adhesion in IR injured colon. The
right panel displays the AUC data for this intravital graph. (B) Ex vivo analysis of the colon and lungs from IR injured mice conﬁrmed that recruitment is lowered in the colon with anti-
CD18ab, but unaltered in the lungs. (C) Blocking either CD18 or CD49d reduced HSC recruitment in the colitis colon. The right panel displays the AUC data for this intravital graph. (D) Ex
vivo analysis of the colon and lungs from colitis injuredmice conﬁrmed these results and that recruitment remained unaltered in the lungs. For all experiments N ≥ 5mice. Data presented
as mean ± SEM. Statistical analysis performed using 1 way ANOVA with Bonferroni post-test comparisons.
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pre-treatment signiﬁcantly (p b 0.05) increased HPC7 adhesion within
IR injured small intestinal ileum (Fig. 3H). To further test this, we intra-
vitally imaged the small intestinal ileumwhere H2O2 pre-treated HPC7s
were present in abundance (Fig. 3H: right side).
4.4. Pre-treating HPC7s with PES, but not PMPs, enhances adhesion within
colitis colon in vivo
Expression levels of the platelet surface markers GPIb and GPIIb
were increased on HPC7s following incubation with either PES or PMP
(Fig. 4A). Interestingly, GPIIb was found to be expressed on naïve
HPC7s, but this was not surprising as it is found on early haematopoietic
progenitor cells (Fig. 4A). DiOC6, used to label PMPs, was observed onHPC7s incubated with PES and PMP (Fig. 4B). HPC7s incubated
with PES or PMP also expressedmore platelet GPIbwhen imaged confo-
cally (Fig. 4B). HPC7s incubated with PES demonstrated a signiﬁcantly
(p b 0.001) increased adhesion on murine colonic endothelial cells
when compared with vehicle controls (Fig. 4C). However, PMP
pre-treatment failed to modulate adhesion in vitro (Fig. 4C). Intravitally
it was observed that PES, but not PMPs, marginally but again not signif-
icantly, increased adhesion within the IR injured colon (Fig. 4D), which
was conﬁrmed by AUC analysis of the date (Fig. 4D: right side). Ex vivo
analysis of IR injured colon did not showany changes although, interest-
ingly, PES pre-treatment did signiﬁcantly (p b 0.01) increase recruit-
ment to the lungs of intestinal IR injured mice (Fig. 4E). PES treatment
did signiﬁcantly (p b 0.05) increase adhesion within the colitis colon
(Fig. 4F), which was conﬁrmed by AUC analysis of the date (Fig. 4F:
Fig. 3. Pre-treatment of HSCswith H2O2 increases adhesion in colitis colon. (A) H2O2 is signiﬁcantly increased in IR and somewhat raised in colitis colon as determined bymeasuring H2O2
content in homogenised tissue. (B) 8-Oxo-dGwas detected in both IR and colitis colon and reﬂects oxidative damage following inﬂammatory injury. (C)HSC adhesionwas enhanced on all
colon tissue sectionswhen pre-treatedwithH2O2. (D)H2O2 did not increaseHSCwithin IR injured colon. The right panel displays theAUC data for this intravital graph. (E) Ex vivo analysis
also demonstrated no enhancedHSC adhesion to colon or pulmonary tissue. (F) H2O2 did increase HSC recruitment to colitis colon. The right panel displays the AUC data for this intravital
graph (G) This increase was conﬁrmed by ex vivo analysis but pulmonary recruitment again remained unchanged. Ex vivo analysis revealed that H2O2 pre-treatment signiﬁcantly
(p b 0.05) increased HPC7 adhesion within IR injured small intestinal ileum (H). Intravital images of the small intestinal ileum also conﬁrmed that H2O2 pre-treated HPC7s were present
in abundance in this region (H). For IVM experiments, N = 6 for all groups. Data presented as mean+ SEM. Statistical analysis performed using 1 way ANOVAwith Bonferroni post-test
comparisons. *p b 0.05.
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Fig. 4. Pre-treatment ofHSCswith PES/PMPs increases adhesion in colitis colon. (A) HSCs incubatedwith PES (blue line) or PMPs (green line) are coatedwithmicroparticles as indicated by
the increase in GPIIb (top) and GPIb (bottom) expression, compared with thrombin (black line). Isotype control is shown as black ﬁll. (B) Upper panels are confocal images of green mi-
croparticles labelled with DiOC6 attached to HSCs. In the lower panels CTO labelled HSCs (red) are interacting with microparticles labelled with an anti-GPIb monoclonal antibody and
counterstained with Alexa Fluor-488 antibody (green). Scale bar = 5 μm. (C) PES pre-treatment increased HSC adhesion to colon endothelial cells in vitro. Representative images are
shown. (D) Neither PES or PMP pre-treatment enhanced HSC adhesion within IR injured colon. The right panel displays the AUC data for this intravital graph. (E) Ex vivo analysis dem-
onstrated increased adhesion within the lungs following PES pre-treatment. (F) PES pre-treatment enhanced adhesion within colitis colon in vivo and lowered pulmonary (G) retention.
For IVM N ≥ 5 across all groups. Data presented as mean + SEM. Scale bars are 5 μm. Statistical analysis performed using 1 way ANOVA with Bonferroni post-test comparisons. *p b 0.05,
**p b 0.01, ***p b 0.001.
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colitis injured colon, but the difference was not signiﬁcant (Fig. 4F).
Again, these observations were conﬁrmed when the colon was investi-
gated ex vivo and reduced (p b 0.05) retention was also observed in the
lungs of coliticmice (Fig. 4G). Therewas no effect observed on the num-
ber of free ﬂowing HPC7s within the IR or colitic injured colon (data not
presented).
4.5. PES/PMPs modulate HPC7 adhesion by increasing surface integrin
clustering and their afﬁnity for endothelial counterligands
Electron micrographs demonstrated that PES and PMP incubation
triggered an activated HPC7 phenotype in which they exhibited
membrane rufﬂing and extension of pseudopodia (Fig. 5A). This HPC7
phenotype has also been demonstrated previously by us following
H2O2 pre-treatment (Kavanagh et al., 2013a). PES pre-treatmentsigniﬁcantly increased adhesion to immobilise endothelial
counterligands, ICAM-1 (p b 0.01) and VCAM-1 (p b 0.001; Fig. 5B).
However, PMP pre-treatment only resulted in a signiﬁcant (p b 0.01) in-
crease toVCAM-1 coated surfaces (Fig. 5B). PES and PMPhadnoeffect on
CD18 or CD49d surface expression (Fig. 5C). The number of CD18 clus-
ters increased with both PES and PMP (p b 0.05) (Fig. 5D), whereas
PES only triggered an increase in CD49d clustering (p b 0.05; Fig. 5D).
There were no signiﬁcant differences in the size of the integrin clusters
(Fig. 5D).
5. Discussion
The clinical success of haematopoietic stem/progenitor cell (HSPC)
therapy for large bowel disorders is poor, partly due to their limited re-
cruitment following systemic administration. However, cellular therapy
may be made effective if systemically transplanted cells are targeted
Fig. 5. PES/PMPsmodulate HSC recruitment by increasing their integrin clustering and afﬁnity for endothelial counterligands. (A) Thrombin treated HSCs demonstrated pseudopodia, but
this was increased following PES and PMP pre-treatment. PES and PMP pre-treatments also increased membrane rufﬂing (insert). (B) PES pre-treatment signiﬁcantly enhanced HSC
adhesion to ICAM-1, but both increased adhesion to VCAM-1. (C) Pre-treatment of HSCs with thrombin (yellow), PES (light blue) or PMP (dark blue), failed to increase surface expression
of CD18 or CD49d compared with vehicle (black line) controls. Isotype control represented as black ﬁll. N = 3 (D) PES and PMP signiﬁcantly increased CD18 cluster number but not size,
whereas, PES increased only CD49d cluster number. Data presented as mean + SEM. Scale bars are 5 μm. Statistical analysis performed using 1 way ANOVA with Bonferroni post-test
comparisons. *p b 0.05, **p b 0.01, ***p b 0.001.
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variety of inﬂammatory bowel diseases such as ulcerative colitis and
Crohn's disease. The colon is highly susceptible in humans (and mice)
to inﬂammatory bowel disorders, with approximately 60% of patientswith Crohn's disease suffering from colonic involvement (Mills and
Stamos, 2007). Although the colon is a site affected bymany inﬂamma-
tory disorders, the dynamics of HSPC recruitment within the colonic
microcirculation has not previously been imaged experimentally.
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immortalised HSC-like line with factors released during or at injury
sites could enhance their adhesion within the murine colon. These
pre-treatments were tested in two different inﬂammatory injuries.
Our novel data provides the ﬁrst evidence that immortalised HSC-like
HPC-7 adhesion within the injured colonmicrovessels can occur almost
immediately after their systemic infusion. Within the colon, we show
that recruitment is not a passive event but is actively regulated by injury
speciﬁc surface receptors, namely CD18 and/or CD49d.More important-
ly, recruitment achieved by injury alone was not maximal as pre-
treatment strategies could enhance the local presence of HPC7s. Indeed,
both chemical (H2O2) and biological (PES) pre-treatment strategies en-
hanced HPC7 adhesion in vitro, but only to the colitis colon in vivo.
These approaches were utilised as both H2O2 generation and PMP for-
mation are known to be elevated following intestinal IR and colitis inju-
ry (Fraticelli et al., 1996; Kavanagh et al., 2013a; Chamouard et al.,
2005). However, while PMPs are elevated in both these injuries, only
PES was effective in increasing HPC7 adhesion whereas PMPs were
not. The development of strategies that enhance colon homing through
modulation of HPC7 integrin afﬁnity (or avidity/expression) may be a
worthwhile clinical pursuit if associated with improved therapeutic
beneﬁt.
Increased HPC7 adhesion within IR and colitis injured colon was
observed on both frozen tissue sections and in vivo when compared
with un-injured colon. Increased adhesion observed in vivo was not
due to a reactive hyperaemia, an increased blood perfusion, often asso-
ciated with tissue injury. Interestingly, blood ﬂow within the exposed
colonic mucosa was signiﬁcantly reduced to a similar degree following
both injuries as determined by laser speckle microscopy. In similar ex-
perimental models of DSS-induced colitis in mice, a modest decrease
in blood ﬂow within the resistance arterioles of the colon submucosa
has been demonstrated at days 4 and 6 post-DSS (Mori et al., 2005b).
However, the current study is the ﬁrst to demonstrate that the mucosal
lining of the colon also undergoes a signiﬁcant reduction in blood ﬂow
post-injury. Since preservation of the gut lumenal lining is essential to
ensure nutrient absorption and prevent bacterial translocation, it was
reassuring to observe that systemically infused HPC7s could still be
recruited to the mucosa despite the poor perfusion in this region. This
has important clinical implications as many inﬂamed organs suffer
from poor blood ﬂow. Indeed, in ulcerative colitis patients, a reduction
in ﬂow is often detected in the chronically inﬂamed and remodelled
colon (Hulten et al., 1977). It is possible that this reduced perfusion re-
sulted in increased HPC7 adhesion due to lower shear rates. Reduced
blood ﬂow in injury sites may be more conducive to adhesive
stem-endothelial cell interactions taking place. Therefore, systemically
delivered SCs may have advantages over pharmacological drugs for
the targeted treatment of inﬂammatory diseases of the colon.
Although it is possible that reduced shear stresses in the injured
colonmay have favoured HPC7 adhesion, this study suggests that active
adhesivemechanisms, similar to those utilised by inﬂammatory neutro-
phils, were actually involved in mediating their recruitment. There has
been much recent discussion surrounding the best and most effective
route for HSPC delivery. This study demonstrates that for the colon,
these cells can be delivered systemically and they can home to and be
actively captured by inﬂamed colonic vasculature. Interestingly, the
adhesive mechanisms governing recruitment varied in the same tissue
depending on the type of injury incurred with either CD18 only or
both CD18 and CD49d utilised. This differential use of integrins is likely
due to the timeframe of the injury investigated. VCAM-1, the
counterligand for CD49d, is known to be expressed as a result of injury
but its expression requires time. This is unlike ICAM-1, the CD18
endothelial counterligand which is expressed constitutively. The time
window in which the IR injury was investigated was 1–2 h post-
reperfusion, which was likely too short a period for expression of
VCAM-1. However, the colitis injury, established over 1 week, is
known to exhibit VCAM-1 in the colitis colon vasculature (Sorianoet al., 2000). As well as the adhesive mechanisms varying depending
on the injury to the organ, we have previously demonstrated that site-
speciﬁc mechanisms also occur for similar injuries. Within IR injured
SI, adhesion of the same immortalisedHSC-like linewas solely CD18 de-
pendent, whereas in IR injured kidney additional andmultiple adhesion
molecules, including CD49d and CD44 were also involved (White et al.,
2013; Kavanagh et al., 2013b; Kavanagh et al., 2010). Collectively, this
data provides important information on the complexity surrounding
the adhesive mechanisms involved, which is important knowledge to
gain if effective targeted delivery strategies are to be designed.
Having investigated the kinetics of HPC7 homing to two different
colon injuries, we further investigated whether injury mediated
recruitment could be enhanced. H2O2 has been known to increase
leukocyte rolling and chemotaxis (Fraticelli et al., 1996). Furthermore,
we previously showed that H2O2 pre-treatment, at physiologically rele-
vant concentrations, effectively ‘primed’ the same HPC7 cells for maxi-
mal adhesion prior to their systemic delivery (Kavanagh et al., 2013a).
This subsequently improved their retention within injured SI. Increased
H2O2 was also detected in homogenates primarily of IR injured, but also
colitis injured, colon along with increased levels of 8-oxo-dG, a marker
used to indicate signs of tissue oxidative stress. However, H2O2 only en-
hanced HPC7 adhesion within colitis injured colon in vivo. This may be
due to the fact that occlusion of the SMA, which supplies blood to the SI
as well as the colon, would also have led to SI injury. Indeed the SI is
highly susceptible to ischaemic insults and comprises a much larger
length of bowel than the colon. Therefore, many of the pre-treated
HPC7s would have been recruited to the simultaneously injured SI, lim-
iting the pool of circulating HPC7s available for the colon. This has im-
portant clinical implications as the targetting of systemic HSPCs to
sites of injury may be compounded by their retention in other areas
where known or unknown injury also exists.
Enhanced HPC7 adhesion was also observed in the colitis colon
following platelet releasate pre-treatment. Approximately 6–7 control
HPC7s were identiﬁed in the colitis microcirculation intravitally
60 min post-infusion, ~11–12 were identiﬁed after H2O2 pre-
treatment and ~13–14 after PES pre-treatment. Confocal and ﬂow cyto-
metric analyses conﬁrmed physical interactions between microparti-
cles, from PES and PMP supernatants, with HPC7s in a manner similar
to that described by others for HSPCs (Janowska-Wieczorek et al.,
2001; Mause et al., 2010). It is worth noting that others have also
shown that PMPs signiﬁcantly augment the arrest of endothelial pro-
genitor cells on blood vessels and moreover, accelerated and enhanced
their vasoregenerative potential (Mause et al., 2010). Interestingly, the
PES pre-treatment was more effective than the PMPs in enhancing
adhesion both in vitro to endothelial cells and in vivo. This suggests
that activated platelets release important soluble factors that, in
addition to themembrane fragments, modulate HSPC adhesion. Indeed,
it has previously been demonstrated that platelets, often found adher-
ent in abundance in ischaemic and inﬂammatory environments, may
guide the homing of HSPCs to sites of injury (de Boer et al., 2006). Fur-
ther characterisation of the chemical and cellular factors involved in this
process may contribute to the development of other innovative strate-
gies to augment HSPC mediated tissue repair for colon pathophysiolog-
ical conditions. It is not clear whether the transfer of platelet adhesion
molecules such as GPIbα, an integrin that allows platelets to tether to
immobilised von Willebrand factor, aided in modifying HPC7 recruit-
ment. This would need to be determined using an anti-GPIb antibody
in our animal models. If transfer of GPIbα is useful, improving the pro-
tocol to generate a greater number of PMPs or improving the coating
of HSPCs with PMPs could be a worthwhile pursuit.
In addition to PES pre-treatment increasing HPC7 adhesion within
the colon, it also concomitantly reduced pulmonary presence, thereby
reducing non-speciﬁc retention in healthy tissues. Pulmonary entrap-
ment is a major obstacle for systemic HSPC delivery for regenerative
purposes both experimentally and clinically (Fischer et al., 2009).
Indeed, patients receiving exogenous HSCs for haematologic disorders
579A. Yemm et al. / Stem Cell Research 15 (2015) 569–580experience post-transplant pulmonary injury due to cells becoming
trapped in lung capillaries. In addition to promoting lung damage,
pulmonary entrapment signiﬁcantly reduces the available pool of
circulating transplanted cells available for recruitment to injured
tissues. This study is the ﬁrst to demonstrate that microparticle coating
not only effectively enhanced recruitment into speciﬁc sites of tissue in-
jury, but also concomitantly decreased their entrapment within lungs.
This observation may simply be related to cell availability, i.e. enhanced
intestinal recruitment means less cells are available for pulmonary
entrapment and vice-versa.
The mechanisms by which microparticles and activated platelet
releasate may modify HPC7 adhesion appear to be similar to those we
have previously seen with H2O2 (Kavanagh et al., 2013a). Although no
change in the actual expression of HPC7 surface integrins was induced,
the number of CD18 and/or CD49d clusters did increase. Evidence is
emerging that the dynamic reorganisation of surface integrins into
microclusters, through F-actin polymerisation, is the major mechanism
regulating integrin binding strength and is a prerequisite for their
activation and ligand binding (van Kooyk and Figdor, 2000). Hence,
these observed changes in integrin clustering may play a major role in
microparticle modiﬁcation of HPC7 adhesion. Electron microscopic
examination of the HPC7 surface also revealed that PMP/PES induced
rufﬂing of the cell membrane and the extension of cellular protrusions,
reminiscent of pseudopodia and ﬁlopodia. These phenotypic changes
are often features of cellular activation. Indeed, macrophages have
been shown to ‘rufﬂe’ following activation with lipopolysaccharide,
but prior to antigen binding, suggesting that this is a direct cellular effect
during activation (Patel and Harrison, 2008). Since cell migration
requires the coordinated formation of ﬁlopodia at the cell front, the de-
velopment of such structures prior to administration may enable HPC7
to increase their migratory responses to local chemokines and thus
improve their subsequent adhesion. Rufﬂing could also be a means by
which cells potentially regulate the clustering and positioning of cell
surface receptors so as to enhance ligand binding (Lim and Hotchin,
2012). This may also contribute to the enhanced adhesion of HPC7
following PES/PMP pre-treatment.
In conclusion, although evidence suggests that HSPCs are beneﬁcial
following tissue injury, the efﬁcacy of such therapies is likely to be
proportional to the degree of cell recruitment which can be achieved.
Indeed, we have recently demonstrated that increasing the local
presence of the same immortalised HSC-like line (HPC7) in the mouse
small intestine was associated with signiﬁcantly reduced neutrophil in-
ﬁltration at 4 h post-reperfusion injury (Kavanagh et al., 2013b). Hence
a greater local presence of HPC7swas required for an anti-inﬂammatory
beneﬁt to be realised. Enhancing the effectiveness of regenerative
processes, particularly in diseases where leukocytes are key players in
mediating injury, may therefore depend on identifying and thenmodu-
lating the adhesive mechanisms that underpin HSPC trafﬁcking. This
study demonstrated that HPC7 recruitment to different injuries of the
colon is increased, but that this recruitment can only be increased fur-
ther in colitis mice. This can be achieved by chemical and biological
pre-treatment strategies in the form of H2O2, PMPs or platelet releasate.
Observed enhanced adhesion was obtained by a short pre-treatment
duration that may be translated into clinical settings as an adjuvant to
cellular therapy. Our observations that individual pre-treatments are
effective only in certain organs or diseases are novel as it highlights
how a single universal approach may be difﬁcult to identify. Previous
studies have enhanced SC recruitment using genetically modiﬁed cells
including the local introduction of genes which encode for the potent
SC chemoattractant SDF-1α. However, the clinical applicability of such
techniques is debatable and may be associated with aggravated tissue
injury due to side effects such as SDF-1α-dependent lymphocyte re-
cruitment. The current study offers the beneﬁt of not requiring genetic
manipulation and, crucially, does not require manipulation of host
tissues to achieve enhanced recruitment. The data in this study may
help in the design of future cellular therapies using haematopoieticprogenitors. It is anticipated that enhancing their recruitment to injured
organs may expedite the recovery process and encourage therapeutic
success clinically in the ﬁeld of regenerative medicine.
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